MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

A.I. Advisor
published Earnings

LXEO is expected to report earnings to fall 8.08% to -91 cents per share on August 18

Lexeo Therapeutics LXEO Stock Earnings Reports
Q2'25
Est.
$-0.91
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.13
The last earnings report on May 13 showed earnings per share of -99 cents, missing the estimate of -88 cents. With 52.98K shares outstanding, the current market capitalization sits at 239.68M.
View a ticker or compare two or three
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXEO showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com